89bio, Inc. Stock Performance

Open N/A	Prev. Close N/A	Circuit Range N/A
Day Range N/A	Year Range N/A	Volume N/A
Average Traded N/A

89bio, Inc. Share Price Chart

$0.00$0.00

89bio, Inc. Stock Fundamentals & Key Indicators

Market Cap N/A	PE Ratio (TTM) N/A	Dividend Yield N/A
EPS (TTM) $-3.51	Revenue (TTM) N/A	Return On Equity (TTM) -91.59%
Profit Margin N/A	Debt to Equity 0.09	Quarterly Earnings Growth YoY -132.44%

89bio, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Revenue	N/A	N/A	N/A	N/A	N/A
Net Profit	-$51.68M	-$47.97M	-$149.07M	-$71.28M	-$111.50M
Net Profit Margin	N/A	N/A	N/A	N/A	N/A
Income Change	N/A	7.18%	-210.76%	52.19%	-56.44%

89bio, Inc. Annual Profit & Loss

All figures in USD

Particulars	2021	2022	2023	2024
Revenue	N/A	N/A	N/A	N/A
Net Profit	-$90.12M	-$102.03M	-$142.19M	-$367.08M
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-13.21%	-39.37%	-158.16%

About 89bio, Inc.

89bio, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of metabolic dysfunction-associated steatohepatitis and hypertriglyceridemia. The company was founded in 2018 and is headquartered in San Francisco, California.

89bio, Inc. Historical Returns

Month	Open	Close	Change %

ETNB Share Price FAQs

What is 89bio, Inc. share price today?

89bio, Inc. share price today is $0.00 as on September 20, 2026 at 7:39 pm IST.

What is the 52 week high and 52 week low of 89bio, Inc. stock?

52 week high/low data for 89bio, Inc. is currently unavailable.

What is ETNB's net income for the last quarter?

ETNB's net income for the last quarter is -0.11B USD.

Can I buy ETNB shares in India?

Yes. You can buy ETNB in India by opening an international trading account.